C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia
暂无分享,去创建一个
[1] Fernando Saldías-Peñafiel,et al. [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker]. , 2019, Revista medica de Chile.
[2] B. Everts,et al. C-Reactive Protein Promotes Inflammation through FcγR-Induced Glycolytic Reprogramming of Human Macrophages , 2019, The Journal of Immunology.
[3] T. Ueland,et al. Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study , 2019, ERJ Open Research.
[4] R. Farah,et al. Consecutive Measures of CRP Correlate with Length of Hospital Stay in Patients with Community-Acquired Pneumonia. , 2018, The Israel Medical Association journal : IMAJ.
[5] Gernot Rohde,et al. Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia , 2017, Infectious diseases.
[6] N. Soldevila,et al. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons , 2017, Human vaccines & immunotherapeutics.
[7] P. Ravn,et al. The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia , 2015 .
[8] H. Yoon. Changes in the epidemiology and burden of community-acquired pneumonia in Korea , 2014, The Korean journal of internal medicine.
[9] F. Blasi,et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. , 2013, Chest.
[10] W. Nseir,et al. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. , 2013, Journal of critical care.
[11] L. F. Ramos-Lima,et al. Biomarkers in community-acquired pneumonia: A state-of-the-art review , 2012, Clinics.
[12] M. Mantero,et al. Understanding the burden of pneumococcal disease in adults. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] T. Welte,et al. Biomarkers in community-acquired pneumonia , 2012, Expert review of respiratory medicine.
[14] P. Póvoa,et al. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study , 2012, Critical Care.
[15] T. Schaberg,et al. Guidelines for the management of adult lower respiratory tract infections ‐ Full version , 2011, Clinical Microbiology and Infection.
[16] T. Welte,et al. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[17] S. Mody,et al. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US , 2009, Current medical research and opinion.
[18] A. Hill,et al. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. , 2008, The American journal of medicine.
[19] P. Póvoa,et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course , 2007, Critical care.
[20] Mark B Pepys,et al. C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.
[21] M. Fine,et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. , 2000, The American journal of medicine.
[22] Sheldon P Stone,et al. Community-acquired pneumonia , 1998, The Lancet.
[23] J. Volanakis,et al. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. , 1974, Journal of immunology.
[24] A. Ortqvist,et al. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. , 1995, Scandinavian journal of infectious diseases.
[25] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.